EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
Collaboration yields promising Barriolide therapy Enterothelin
Read More
Tag: UC
EMA to consider expanding use of Merck/Pfizer’s Bavencio
The regulator will assess its safety and efficacy as a treatment for bladder cancer
Read More
NICE u-turn backs Stelara for UC
Stelara is the first biologic therapy for UC that targets interleukin (IL)-12 and IL-23 cytokines
Read More
Entyvio beats Humira in head-to-head ulcerative colitis trial
Results offer new insight to support treatment decisions, Takeda says
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
